Radiotherapy for breast cancer

Journal of the National Cancer Institute

Volumn 97, Issue 6, 2005, Pages 406-407

  Cuzick, Jack ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; BREAST CANCER; CANCER MORTALITY; CANCER RELAPSE; CARDIOVASCULAR RISK; EDITORIAL; FOLLOW UP; HEART DEATH; HUMAN; IMMUNE RESPONSE; LIFE EXPECTANCY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RISK ASSESSMENT; RISK REDUCTION; TREATMENT OUTCOME; ADJUVANT THERAPY; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HEART MUSCLE ISCHEMIA; IMMUNOLOGY; MORTALITY; NOTE; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH; TUMOR RECURRENCE;

BREAST NEOPLASMS; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; MYOCARDIAL ISCHEMIA; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT;

EID: 14944375383     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/dji086     Document Type: Editorial

References (11)

1. Paterson R, Russell MH. Breast cancer: evaluation of post-operative radiotherapy. J Fac Radiol 1959;10:174-180.
2. Palmer MK, Ribeiro CG. Thirty-four year follow-up of patients with breast cancer in a clinical trial of postoperative breast cancer. Br Med J 1985;291:1088-91.
3. Stjernsward J. Decreased survival related to irradiation postoperatively in early operable breast cancer. Lancet 1977;ii:1285-6.
4. Cuzick J, Stewart H, Peto R, Baum M, Fisher B, Host H, et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 1987;71:15-29.
5. Rutqvist LE, Lax I, Fornander T, Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 1992;22: 887-96.
6. Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994;12:447-53.
7. EBCTCG. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000;355;1757-70.
8. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949-55.
9. Hojris I, Overgaard M, Christensen JJ, Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet 1999;354:1425-30.
10. Giordano SH, Kuo Y-F, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 2005;97:419-24.
11. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-34.